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Objective: to investigate the effects of respiratory training with a speciﬁc device
(SpiroTiger®) on lung function, quality of life perception, attitudes toward physio-
therapy and need for antibiotic treatment in cystic ﬁbrosis (CF).
Design: Twenty-four patients (mean age 21.1, SD 6.6) with CF were prospectively
enrolled in an open-label one year observational study.
Interventions: baseline and post intervention measures were determined by lung
function (FVC, FEV1, FEF 25−75), quality of life perception (Borg scales), attitudes
toward physiotherapy (questionnaires) and need for antibiotic treatment in the year
before and in the year of intervention. Each patient acted as a control of himself.
Compliance to physiotherapy was monitored through the speciﬁc device software.
Results: following respiratory training, signiﬁcant increases in lung function
(FEV1% predicted mean and standard deviation from 82 (20.09) to 88.8 (21.9)
p< 0.01) and quality of life perception (Borg scales mean and standard deviation
from 6.1 (1.2) to 9.1 (0.8) p< 0.001) were noted with a reduction in need for
intravenous antibiotic treatment (cycles per year mean and standard deviation from
1.8 (1.4) to 1 (1.3) p< 0.001). Compliance to treatment was good/acceptable in 92%
of patients. Patients preferences favoured respiratory training in respect to Positive
expiratory pressure.
Conclusions: respiratory training with a speciﬁc device resulted in signiﬁcant
beneﬁts for CF patients including lung function tests, quality of life perception,
need for intravenous antibiotic treatment. Participants preferred respiratory training
to PEP.
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Introduction: the major part of CF patients receive nebulized drugs on a daily
basis. The nebulizer has been proved to be a possible source of contamination of
the respiratory tract. With the upcoming of vibrating-mesh nebulizers (Aeroneb®,
E-Flow®), new methods concerning the hygiene of this material emerge. This survey
aims to analyze the household methods used by CF patients.
Method: a questionnaire analyzing maintenance and hygiene of nebulizers has
been established by the physiotherapists of the Belgian CF centres. The Belgian CF
Association sent this to every CF patient. The replies concerning vibrating-mesh
nebulizers were analysed separately.
Results: 196 (52%) of the 379 responding patients use a vibrating-mesh nebulizer.
86% of the systems are cleaned. 90% of the systems are disinfected, whereof 52%
at least once a day. A thermal disinfection, a hypochlorite-based solution or an
acetic acid solution is used respectively by 51%, 15% and 19% of the patients.
Thermal disinfection is done by means of a steriliser (22%) or with boiling water
(29%). In 68%, disinfection is followed by rinsing. Even after thermal disinfection,
53% of the patients rinse the system. After cleansing and/or disinfection, 79% of
the patients dry the nebulizer.
Conclusion: Although the vibrating-mesh nebulizer has been introduced recently,
already half of the Belgian patients use it. Lack of guidelines stipulating hygienic
methods for these nebulizers enhance confusion of patients and although it is
disadvised, hypochlorite solution and acetic acid remain largely used. An update of
the guidelines is recommended.
Supported by: The Belgian CF Association.
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Introduction: The majority of cystic ﬁbrosis patients has to inhale nebulized
drugs on a daily basis. Nebulizers are a potential source of contamination of the
respiratory tract. Nevertheless, only few precise guidelines regulating the cleansing
and disinfection of these are available. This survey aims to analyze the common
household methods used by CF patients.
Material and Method: A questionnaire asking about the type of nebulizer, methods
and frequency of cleansing, disinfection and drying of the nebulizer has been
established by the physiotherapists of the Belgian CF centres. The Belgian CF
Association sent this questionnaire to every Belgian patient.
Results: From the 903 distributed questionnaires, 379 (42%) returned. Respectively
40, 52 and 8% of the patients use a jet nebulizer, a vibrating-mesh nebulizer or an
ultrasonic device.
88% of the patients clean their material, whereof 38% with soap. Disinfection
is done by 90% of the patients whereof 55% less than once a day. A thermal
disinfection (boiling water or steriliser), a hypochlorite-based solution or an acetic
acid solution is used respectively by 39%, 25% and 11% of the patients. Thermal
disinfection is used by 26% and 51% of patients using respectively a classical or a
vibrating-mesh nebulizer. After being cleaned or disinfected, 85% of the material
is being dried.
Conclusion: The high percentage of patients disinfecting their nebulizer proves that
they seem aware of the hygiene problem. Lack of unanimous guidelines explains
the various methods they use. The upcoming of vibrating-mesh nebulizer leads to
a change in disinfection methods.
Supported by: The Belgian CF Association.
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Nebulizations, frequently used by cystic ﬁbrosis patients (CF), are a potential source
of bacterial contamination of the respiratory tract.
Purpose of the study: The objectives of this study are to assess the habits of patients
regarding the methods of disinfecting the nebulization equipment (Phase 1), and
to observe the effect of standardised recommendations which has been validated
in vitro (Phase 2).
Material and Method: A randomised sample of 50 CF patients was studied.
During two home visits, a questionnaire about the routine methods of the equipment
cleaning was completed by the nurses, sputum samples were taken from the patients
and bacteriological samples from the equipment. The ﬁrst visit (Phase 1) took
place before implementation of the recommendations; for the second (Phase 2),
compliance with the proposed recommendations was requested.
Results: Phase 1 showed a great diversity in practices. The results of the samples
showed contamination of the equipment by environmental (43%), commensal
(52%) and pathogenic (5%) bacteria, justifying special attention. Disinfection
using a hypochlorite-based solution (Phase 2) showed an effect on the rate and
degree of contamination, but did not decrease the number of pathogens found on
the equipment. The cooling chamber of the ultrasonic equipment was the most
contaminated part. No concordance was shown between the germs found in the
samples taken from the nebulizers and the sputum samples.
Conclusion: Disinfection of the nebulizers would seem to be indicated in cystic
ﬁbrosis.
Supported by: The Belgian CF Association.
